Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by oxinoson Aug 13, 2020 8:20am
155 Views
Post# 31402077

News!,

News!,

QuestCap Announces Opening of Second Collection Sites, LLC Las Vegas Testing Centre

C.QSC 

The Launch of the Second Pop-Up Lab Powered By Alcala Laboratories Doubles Daily Testing Capacity

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- QuestCap Inc. (“QuestCap) (CSE:QSC; FRA:34C1) is pleased to announce that its portfolio company Collection Sites, LLC has opened a second pop-up testing center in Las Vegas. The draw center run is in conjunction with Alcala Testing and Analysis Services, a CLIA registered high complexity laboratory based in San Diego, California. Alcala is a recognized expert leader in rapid COVID-19 laboratory testing.

The new Centre will offer antibody testing for $49/test, with the capacity for 500 tests per day. With the opening of the second location, daily testing capacity has increased to 1,000 antibody tests/day at an average price of $49. The antibody tests take 8-10 minutes to administer and return same-day certified lab results. The results can be communicated via text or email and can be accompanied with a certificate of good health via proprietary HIPAA-compliant Alcala iPhone and Android applications.

The new testing center will offer convenient access to antibody testing with insurance coverage options. Appointments and payments will be handled through an online portal www.testbeforeyougo.comto limit contact points at the centers. “Collection Sites LLC is quickly implementing their strategy of opening multiple locations over the next couple weeks servicing Nevada, Arizona, Texas and Indiana offering convenient, on-site testing capability utilizing their CLIA registered partner, Alcala Labs” says Mr. Doug Sommerville, CEO of QuestCap.


<< Previous
Bullboard Posts
Next >>